Aller au contenu
Aperlena
Langue:

Radiotherapy Quality Assurance (RTTQA)

Attribué Avis d'attribution Aucune date limite publiée
Suivre ce marché

Nous vous écrivons si la date limite change ou si un rectificatif est publié. Gratuit. Se connecter

  1. Publié
  2. Attribué en attente

Description

This is a business case to fund a Radiotherapy Quality Assurance (RTTQA) programme provided by the QA team hosted at Mount Vernon Cancer Centre. The team will lead the pre-assessment quality assurance of up to 30 radiotherapy providers to enable local delivery of for renal Stereotactic Ablative Radiotherapy (SABR) cancer and Stereotactic radiosurgery (SRS) for essential tremor, both of which are new clinical indications recently supported for routine commissioning via Clinical Priorities Advisory Group (CPAG) prioritisation following the policy development process. The team hosted at Mount Vernon Cancer Centre (MVCC) hosted at East and North Herts NHS Trust, is the sole provider of this service in the UK. QA plays a fundamental part to clinical trial participation in the UK and is led by the RTTQA team. The experienced team has led the QA process previously as part of the NHS England specialised commissioning SABR commissioning through evaluation programme from 2015-2018, SRS RTTQA following the reprocurement of the SRS/SRT service in 2024, and completion of a multiyear programme of SABR rollout for several clinical indications including primary lung cancer and simple oligometastatic disease and more recently pancreatic cancers. QA is fundamental to ensuring the safe and effective rollout of renal SABR and SRS for essential temor in England over the next 12 months. This approach will ensure that all eligible centres deliver SABR to these very complex tumours to a consistently high quality standard to minimise risks to patients thus reducing unwarranted variation in clinical practice. Once completed eligible radiotherapy providers in England will be able to deliver SABR for renal cancers and SRS for eligible patients with essential tremor. Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to Radiotherapy quality Assurance (RTTQA) commencing 01.07.2026

Source officielle

Source : Find a Tender Service (UK Cabinet Office / Crown Commercial Service)

Vérifiez toujours les détails dans l'avis officiel.

Dernière vérification auprès de Find a Tender Service (UK Cabinet Office / Crown Commercial Service) il y a 4 semaines

Documents sur Find a Tender Service (UK Cabinet Office / Crown Commercial Service) (anglais)

Consulter l'avis officiel

Plus de cet acheteur

Profil complet de l'acheteur

26 marchés ouverts actuellement

Attributions récentes

Marchés similaires

Contexte de marché

Historique de l'acheteur sur Aperlena
170 avis suivis · 115 attribués
375 853 898 € de contrats attribués

Ne manquez plus aucun marché comme celui-ci

Recevez un e-mail pour les nouveaux marchés : Royaume-Uni. Gratuit.

Créer mon alerte
Source

Raccourcis clavier

Parcourir une liste sans toucher la souris. Les raccourcis restent inactifs pendant la saisie dans un champ.

j
Résultat suivant
k
Résultat précédent
Entrée
Ouvrir le résultat
n
Page suivante
p
Page précédente
c
Comparer ce résultat
s
Ajouter ce résultat à la présélection
/
Aller au champ de recherche
?
Afficher ces raccourcis
Échap
Fermer